SDF 1-alpha Attenuates Myocardial Injury Without Altering the Direct Contribution of Circulating Cells

Fusions of Tumor-derived Endothelial Cells with Dendritic Cells Induces Antitumor Immunity

(2017) Yingying Huang et al.   Scientific Reports

Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial

(2015) Eugene S. Chung et al.   EUROPEAN HEART JOURNAL

Hypoxia fate mapping identifies cycling cardiomyocytes in the adult heart

(2015) Wataru Kimura et al.   NATURE

Migration towards SDF-1 selects angiogenin-expressing bone marrow monocytes endowed with cardiac reparative activity in patients with previous myocardial infarction

(2015) Raimondo Ascione et al.   Stem Cell Research & Therapy

Mesenchymal Precursor Cells as Adjunctive Therapy in Recipients of Contemporary Left Ventricular Assist Devices

(2014) Deborah D. Ascheim et al.   CIRCULATION

Sustained Release of Engineered Stromal Cell-Derived Factor 1-  From Injectable Hydrogels Effectively Recruits Endothelial Progenitor Cells and Preserves Ventricular Function After Myocardial Infarction

(2013) J. W. MacArthur et al.   CIRCULATION

Preclinical Evaluation of the Engineered Stem Cell Chemokine Stromal Cell–Derived Factor 1α Analog in a Translational Ovine Myocardial Infarction Model

(2013) John W. MacArthur et al.   CIRCULATION RESEARCH

Myocardial tissue elastic properties determined by atomic force microscopy after stromal cell–derived factor 1α angiogenic therapy for acute myocardial infarction in a murine model

(2012) William Hiesinger et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Mammalian heart renewal by pre-existing cardiomyocytes

(2012) Samuel E. Senyo et al.   NATURE

Computational Protein Design to Reengineer Stromal Cell-Derived Factor-1  Generates an Effective and Translatable Angiogenic Polypeptide Analog

(2011) W. Hiesinger et al.   CIRCULATION

Plasmid-based transient human stromal cell-derived factor-1 gene transfer improves cardiac function in chronic heart failure

(2011) S Sundararaman et al.   GENE THERAPY

Effect of Intracoronary Delivery of Autologous Bone Marrow Mononuclear Cells 2 to 3 Weeks Following Acute Myocardial Infarction on Left Ventricular Function

(2011) Jay H. Traverse   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

De novo cardiomyocytes from within the activated adult heart after injury

(2011) Nicola Smart et al.   NATURE

Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction

(2010) A. Fantin et al.   BLOOD

Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial

(2009) Michał Tendera et al.   EUROPEAN HEART JOURNAL

Intramyocardial Bone Marrow Cell Injection for Chronic Myocardial Ischemia

(2009) Jan van Ramshorst et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Stromal Cell–Derived Factor-1α Is Cardioprotective After Myocardial Infarction

(2008) Ankur Saxena et al.   CIRCULATION